1/86
Looks like no tags are added yet.
What is the action of Antidiuretic Agents?
Hormonal control of fluid preservation in the medullary collecting duct
What is the action of Uricosuric Agents?
Organic anion transport modulation in the proximal tubule
What is the clinical pivot of Antidiuretic & Uricosuric Agents?
Shifting focus from volume excretion to fluid conservation and metabolic waste clearance
What is the physiological role of Antidiuretic Agents?
Synthesized in the hypothalamus, stored in the posterior pituitary, and released in response to high plasma osmolality
What are the antidiuretic agents?
Vasopressin
Desmopressin
What is the MOA of Antidiuretic Agents (Vasopressin & Desmopressin)
Binds to V2 receptors on the basolateral membrane of the collecting duct
Triggers Gs-protein/cAMP cascade to induce exocytosis of Aquaporin-2 channels into the apical membrane
What is the net effect of Antidiuretic Agents?
Massive water reabsorption, concentrating the urine and lowering blood osmolality.
What is Vasopressin (Endogenous ADH)?
Non-selective: Actively stimulates V1 receptors (vasoconstriction) and V2
receptors (antidiuresis).
Short half life (~15-20 minutes)
primarily used in acute resuscitation or shock
What is Desmopressin (DDVAP)?
Synthetic analogue;
highly selective for the V2 receptor
Long-acting (8-12hours) with no significant V1-mediated vasoconstrictive properties
What is the primary use of Vasopressin?
Various conditions
(shock, diabetes insipidus)
What is the primary use of Desmopressin?
Central Diabetes Insipidus (first line)
Nocturnal enuresis
What is the strength of Vasopressin V1a receptor selectivity?
Strong agonist
What is the strength of Desmopressin V1a receptor selectivity
Minimal V1a affinity
What is the V2 receptor selectivity of Vasopressin?
Strong V2 agonist
(Effect: Diuresis)
What is the V2 receptor selectivity of Desmopressin?
Potent & Highly Selective V2 agonist
(Effect: Potent Antidiuresis)
What are the key indications for Vasopressin & Desmopressin?
Central Diabetes Insipidus (V2 effect)
Nocturnal enuresis, and Von Willebrand disease (induces endothelial release of Factor VIII and vWF
What is a major adverse effect of Antidiuretics?
Water intoxication
Excessive water retention leads to
dilutional hyponatremia
What are the symptoms of Antidiuretic toxicity?
Headache, nausea, confusion
Seizures, cerebral edema
What is a Vasopressin specific risk?
HTN
MI
Localized tissue necrosis due to seere V1 vasoconstriction
What is the clinical monitoring for Antidiuretic Toxicity?
Obtain baseline and periodic serum sodium levels
Strictly counsel patient to limit fluid intake for 8 hours following administration to prevent fluid overload
What is the target condition of Uricosuric Agents?
Chronic tophaceous gout stemming from under-excretion of uric acid
What are the prototype Uricosuric Acid Drugs?
Probenecid
Sulfinpyrazone
What is the MOA of Uricosuric Agents?
Competitively inhibits active organic anion transporters (URAT1 and OAT4) in the brush border of the proximal tubule
What is the net effect of Uricosuric agents?
Blocks the reabsorption of filtered uric acid, causing it to stream out in the urine
What is the major adverse effect of Uricosurics?
Nephrolithiasis (Uric Acid Kidney Stones)
High luminal concentrations of uric acid can precipitate out into crystals
What is the paradoxical effect of Uricosurics?
Can acutely trigger or worsen an acute gouty arthritis attack in early in the therapy by mobilizing tissue urate stores
What is the patient education for Uricosurics?
Hydrate = high fluid intake
Avoid aspirin = directly counteract the uricosuric effect of Probenecid
Contraindications of Uricosurics
History of renal impairment or pre-existing uric acid stones
What is the RAAS system?
The fundamental hormonal system controlling systemic blood pressure, fluid volume, and renal hemodynamics
What is the clinical goal of the RAAS system?
Downregulating the vasoconstrictive, aldosterone-releasing and fibrotic pathways of Angiotensin II
What is the scope of the RAAS Modulators?
Moving from traditional first-line blockades (ACEIs, ARBs) to dual-mechanims actions (ARNIs) and cutting-edge exploratory molecules
The counter-regulation of the actions of Ang II by ACE2 occur in at least two ways:
1) It decreases Ang II levels and limits its effects by metabolizing it to Ang(1-7)
2) It increases levels of Ang(1-7), which acts on Mas receptors to oppose Ang II actions
What is the MOA of ACE Inhibitors?
competitively inhibits the angiotensin-converting enzyme (ACE) in pulmonary and vascular endothelium
prevents conversion of inactive Angiotensin I to active Angiotensin II
Inhibits the breakdown of Bradykinin, leading to increased vasodilatory prostaglandins
What is the net renal effect of ACE Inhibitors?
Preferential vasodilation of the efferent arteriole, reducing intraglomerular pressure and halting protein spilling
Adverse effects of ACE Inhibitors
Dry cough & Angioedema
Hyperkalemia
AKI
Teratogenicity
MOA of ARBs
Directly and competitively blocks the Angiotensin II Type 1 (AT1) receptor
Leaves the AT2 receptor unaffected permitting beneficial vasodilatory and antiproliferative signaling
What are the approved ARBs?
Losartan
Valsartan
Irbesartan
Telmisartan
Candesartan & Olmesartan (administered as cilexetil & medoxomil prodrugs)
Azilsartan (Medoxomil prodrug)
What is the clinical advantage of ARBs?
Identical hemodynamic benefit to ACEIs but without the bradykinin accumulation (no dry cough, significantly lower risk of angioedema)
What is the Direct Renin Inhibitor drug?
Aliskiren
What is the MOA of Direct Renin Inhibitors?
Binds directly to the active site of Renin, preventing it from cleaving angiotensinogen
Suppresses Plasma Renin Activity, shutting down the entire downstream synthesis of both angiotensin I and II
What are the clinical limitations of Direct Renin Inhibitors?
Monotherapy for HTN; strictly contraindicated to be combined with ACEIs or ARBs in diabetic patients due to elevated risks of severe hyperkalemia, hypotension, and renal impairment
What are the approved clinical agents for ARNi (Angiotensin Receptor-Neprilysin Inhibitors)?
Sacubitril/Valsartan (Entresto)
What is the MOA of Sacubitril?
A prodrug activated to LBQ657, which inhibits the metalloprotease Neprilysin.
This stops the degradation of endogenous natriuretic peptides (ANP, BNP, bradykinin)
What is the MOA of Valsartan?
Provides concurrent target-organ AT1 receptor blockade
What is the net impact of ARNis?
Combined vasodilation, natriuresis, diuresis, and massive reduction in myocardial remodeling
What is the clinical mainstay of ARNI?
Now considered a preferred frontline therapy for HFrEF (Heart Failure with Reduced Ejection Fraction)
What are the MAS1 Receptor Agonists?
TXA127
AVE0991
What is the concept of MAS1 Receptor?
Stimulating the protective, counter-regulatory RAAS arm that promotes vasodilation, anti-fibrosis, and anti-inflammation
What is TXA127?
An investigational synthetic formulation of Angtiotensin (1-7) designed to bind and activate the MAS1 receptor
What is AVE0091?
A nonpeptide, orally bioavailable MAS1 agonist currently showing highly promising organ protection in preclinical animal models
What is a recombinant Human ACE2
GSK2586881
What is GSK2586881?
Investigational recombinant human ACE2 enzyme
What is the mechanism of GSK2586881?
Directly degrades destructive Angiotensin II while simultaneously generating protective Angiotensin (1-7), pulling the body out of a pro-inflammatory state
What is a Biased AT1 Receptor Agonists?
TRV027
What is TRV027?
An investigational B-arrestin-biased AT1 receptor ligand
What is the mechanism of TRV027?
Uniquely blocks the traditional G-protein signaling pathway responsible for dangerous vasoconstriction, while simultaneously activating the beneficial b-arrestin pathway that promotes cell survival and increases cardiac output.
What is the concept regarding the AT2 Receptor Agonists?
Direct stimulation of the minor, protective Angiotensin II type 2 receptor
What is the status of the AT2 receptor agonists?
Multiple small-molecule agents are undergoing early-phase discovery and preclinical optimization; none are currently approved for clinical use
What are SGLT-2 inhibitors?
Sodium-Glucose Cotransporter 2 inhibitor
What are the SGLT-2 inhibitors (“-gliflozin”) class?
Core agents alter glucose management via the renal pathway
What is the evolution of SGLT-2 Inhibitors?
Began as glycemic control agents; now vital pillars in cardioprotection and nephroprotection
What is the target site of SGLT-2 inhibitors?
proximal convoluted tubule of the nephron
What is the effect of SGLT-2 inhibitors?
Promotes excretion of ~100g of glucose per day
What are the secondary benefits of SGLT-2 inhibitors?
Osmotic diuresis and natriuresis lead to blood pressure reduction and weight loss
What are the insulin-dependent properties of SGLT-2 inhibitors?
lowering glucose does not stimulate insulin secretion, yielding a low risk of hypoglycemia
What is the brand name of Canagliflozin?
Invokana
What are the primary indications for Canagliflozin? (Invokana)
T2D Glycemic Control, MACE reduction, Diabetic Nephropathy
What are the primary indications for Dapagliflozin? (Farxiga)
T2D Glycemic Control, Heart Failure (HFrEF/HFpEF), CKD
What is the brand name for Dapagliflozin?
Farxiga
What is the brand name of Empagliflozin?
Jardiance
What are the primary indications for Empagliflozin?
T2D Glycemic Control, CV Death Risk Reduction, Heart Failure, CKD
What is the brand name for Ertugliflozin?
Steglatro
What are the primary indications for Ertugliflozin?
T2D Glycemic Control
What are the primary indications for Bexagliflozin?
T2D Glycemic Control
What is the brand name for Bexagliflozin?
Brenzavvy
What is the Dual SGLT-1/SGLT-2 inhibitor drug?
Sotagliflozin
What is the brand name for Sotagliflozin?
Inpefa
What is the mechanism of action of Sotagliflozin?
Targets SGLT-2 in the kidneys and SGLT-1 in the GI tract
What is the GI tract impact of Sotagliflozin?
Delays glucose absorption in the gut, minimizing postprandial sugar spikes
What is the primary indication for Sotagliflozin?
Specifically labeled to reduce the risk of CV death and heart failure hospitalizations
What is Sotagliflozin marketed for, but standard management for what?
HF
Glycemic
What are the common risks of Dual SGLT-1/SGLT-2 inhibitors?
Genital mycotic infections (yeast infections)
Urinary Tract Infections (UTIs)
volume depletion/hypotension.
What is the Critical Warning for Dual SGLT-1/SGLT-2 Inhibitors?
Euglycemic Diabetic Ketoacidosis
What is Euglycemic Diabetic Ketoacidosis?
Ketoacidosis can present with perfectly normal or only mildly elevated blood sugars
What are the Canagliflozin specific side effects?
Black box warnings for amputation risk were removed by the FDA, but monitoring lower limb health remains prudent.
What are the renal thresholds for SGLT-1/SGLT-2 inhibitors?
Generally less effective for glucose lowering if eGFR drops below 30 mL/min, though cardiac/renal protective traits persist.